Vimta Labs Q3 Results
- BSE: 524394
- NSE: VIMTALABS
- ISIN: INE579C01029
- Sector: Biotechnology & Drugs
BSE
490.55
23.45 (5.02%)
23.45 (5.02%)Volume54.55 K
Updated: Wed 11 Feb, 2026 | 15:29:36
NSE
491.1524.50 (5.25%)
24.50 (5.25%)Volume1.05 M
Updated: Wed 11 Feb, 2026 | 15:44:31
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹98.63 Cr.(9.69%)
- Operating Profit₹21.70 Cr.(-6.78%)
- Profit After Tax₹17.59 Cr.(0.42%)
- Operating Margin22.00%(-15.01%)
Note: Comparison is on YoY basis
Quarterly - Vimta Labs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 76.94 | 63.13 | -1.18% | 66.65 | 15.44% |
| Depreciation/ Amortization | 10.92 | 8.29 | 6.63% | 9.81 | 11.34% |
| Operating Income | 21.70 | 21.61 | -9.56% | 23.28 | -6.78% |
| Net Income | 17.59 | 15.25 | -11.72% | 21.49 | -18.18% |
| Other Operating Expenses Total | 16.63 | 12.55 | -11.79% | 12.84 | 29.51% |
| Net Income Before Taxes | 23.37 | 21.89 | -11.05% | 23.92 | -2.28% |
| Total Revenue | 98.63 | 84.74 | -3.16% | 89.92 | 9.69% |
| Selling/ General/ Admin Expenses Total | 28.41 | 23.94 | -0.73% | 23.37 | 21.57% |
| Diluted Normalized EPS | 4.21 | 3.77 | -5.13% | 3.89 | 8.15% |